A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography

Nephrology Dialysis Transplantation

Volumn 29, Issue 5, 2014, Pages 1029-1036

  Kooiman, Judith ^a   Sijpkens, Yvo W J ^b   De Vries, Jean Paul P M ^c   Brulez, Harald F H ^d   Hamming, Jaap F ^a   Van Der Molen, Aart J ^a   Aarts, Nico J M ^b   Cannegieter, Suzanne C ^a   Putter, Hein ^a   Swarts, Renate ^a   Van Den Hout, Wilbert B ^a   Rabelink, Ton J ^a   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Acute renal failure; chronic kidney disease; contrast induced acute kidney injury; prevention; randomized controlled trial

Indexed keywords

BICARBONATE; CREATININE; SODIUM CHLORIDE;

ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONVALESCENCE; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; HEALTH CARE COST; HEALTH CARE NEED; HUMAN; HYDRATION; INTENTION TO TREAT ANALYSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE RENAL FAILURE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED-ACUTE KIDNEY INJURY; PREVENTION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; CONTRAST MEDIA; CREATININE; FEMALE; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RENAL INSUFFICIENCY, CHRONIC; SODIUM BICARBONATE; SODIUM CHLORIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899825747     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu025     Document Type: Article

References (49)

1. Seeliger E, Sendeski M, Rihal CS et al. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J 2012; 33: 2007-2015
2. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14: S131-S138
3. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc 2007; 298: 2038-2047
4. Murakami R, Hayashi H, Sugizaki KI et al. Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT. Eur Radiol 2012; 22: 2147-2152
5. Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012; 27: 4263-4273
6. Gurm HS, Dixon SR, Smith DE et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011; 58: 907-914
7. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int Suppl 2006; S16-S19
8. Stacul F, Adam A, Becker CR et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98: 59K-77K
9. Stacul F, van der Molen AJ, Reimer P et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21: 2527-2541
10. Trivedi HS, Moore H, Nasr S et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29-C34
11. Brar SS, Hiremath S, Dangas G et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4: 1584-1592
12. Hogan SE, L'Allier P, Chetcuti S et al. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 2008; 156: 414-421
13. Hoste EA, De Waele JJ, Gevaert SA et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant 2010; 25: 747-758
14. Jang JS, Jin HY, Seo JS et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury-A systematic review and meta-analysis. Circ J 2012; 76: 2255-2265
15. Kanbay M, Covic A, Coca SG et al. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol 2009; 41: 617-627
16. Kunadian V, Zaman A, Spyridopoulos I et al. Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur J Radiol 2011; 79: 48-55
17. Meier P, Ko DT, Tamura A et al. Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Med 2009; 7: 23
18. Navaneethan SD, Singh S, Appasamy S et al. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 617-627
19. Trivedi H, Nadella R, Szabo A. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. Clin Nephrol 2010; 74: 288-296
20. Zoungas S, Ninomiya T, Huxley R et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephro-pathy. Ann Intern Med 2009; 151: 631-638
21. Maioli M, Toso A, Leoncini M et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52: 599-604
22. Meier PP, Gurm HS. Is simpler also better? Brief sodium bicarbonate infusion to prevent contrast-induced nephropathy. Am J Cardiol 2010; 105: 1042-1043
23. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399
24. Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation 2010; 122: 2451-2455
25. Merten GJ, Burgess WP, Gray LV et al. Prevention of contrast-induced ne-phropathy with sodium bicarbonate: a randomized controlled trial. J Am Med Assoc 2004; 291: 2328-2334
26. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
27. Becker CR, Reiser MF. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 2005; 40: 672-675
28. Wi J, Ko YG, Kim JS et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 2011; 97: 1753-1757
29. Hakkaart-van Roijen L. Manual for cost analyses, methods and standard prices for economic evaluations in health care (in Dutch). Tan SS and Bouwmans CAM. 2010. Dutch Health Insurance Executive Board.
30. Zethraeus N, Johannesson M, Jonsson B et al. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003; 21: 39-48
31. Kuhn MJ, Chen N, Sahani DV et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low-or iso-osmolar contrast agent exposure. AJR Am J Roentgenol 2008; 191: 151-157
32. Section 4: Contrast-induced AKI. Kidney Inter Suppl 2012; 2: 69-88
33. Klima T, Christ A, Marana I et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. Eur Heart J 2012; 33: 2071-2079
34. Tamura A, Goto Y, Miyamoto K et al. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. Am J Cardiol 2009; 104: 921-925
35. Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1487-1493
36. Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med 2009; 361: 109-112
37. Porter ME. What is value in health care? N Engl J Med 2010; 363: 2477-2481
38. Franklin J, Phillips R. Efficacy of hydration in the prevention of contrast material-induced nephropathy. Radiology 2012; 265: 977-978
39. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 2004; 183: 1673-1689
40. Sinert R, Brandler E, Subramanian RA et al. Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity? Acad Emerg Med 2012; 19: 1261-1267
41. Slocum NK, Grossman PM, Moscucci M et al. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J 2012; 163: 829-834
42. Coyle LC, Rodriguez A, Jeschke RE et al. Acetylcysteine in diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast ne-phropathy in diabetics. Am Heart J 2006; 151: 1032e.9-1032e12
43. Jo SH, Koo BK, Park JS et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-A randomized controlled study. Am Heart J 2008; 155: 499e1-8
44. Jo SH, Koo BK, Park JS et al. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-A prospective randomized controlled trial. Am Heart J 2009; 157: 576-583
45. Mehran R, Nikolsky E, Kirtane AJ et al. Ionic low-osmolar versus nonio-nic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv 2009; 2: 415-421
46. Ng TM, Shurmur SW, Silver M et al. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). Int J Cardiol 2006; 109: 322-328
47. Rudnick MR, Davidson C, Laskey W et al. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque An-giography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J 2008; 156: 776-782
48. Wessely R, Koppara T, Bradaric C et al. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 2009; 2: 430-437
49. American College of Radiology. Manual on Contrast Media v8. 2012.